Functional Dyspepsia Guideline Quality Assessment: Based on AGREE Ⅱ and RIGHT Tools

doi:10.12114/j.issn.1007-9572.2024.0128

Chinese General Practice ›› 2026, Vol. 29 ›› Issue (17): 2410-2417.DOI: 10.12114/j.issn.1007-9572.2024.0128

Special Issue: 指南/共识最新文章合辑

• Article·Study of Evidence-based Medicine • Previous Articles Next Articles

Functional Dyspepsia Guideline Quality Assessment: Based on AGREE Ⅱ and RIGHT Tools

1. Department of Pediatrics, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China
2. Department of Medicinal Formulas, School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China
3. Department of Pediatrics, Meishan Traditional Chinese Medicine Hospital, Meishan 620010, China

Received:2024-02-14 Revised:2024-06-03 Published:2026-06-15 Online:2026-05-21
Contact: SUN Xiangjuan, ZHANG Fenghua
About author:
TONG Min and WANG Ying are co-first authors

功能性消化不良指南质量评价：基于AGREE Ⅱ和RIGHT工具

1．610072　四川省成都市，成都中医药大学附属医院儿科
2．610075　四川省成都市，成都中医药大学基础医学院方剂教研室
3．620010　四川省眉山市中医医院儿科

通讯作者: 孙香娟, 张丰华
作者简介:
童敏和王颖为共同第一作者
作者贡献：
童敏、王颖、徐衍燊、曾永渐、文华、刘学负责提取、分析、解读数据，统计分析以及图、表制作；童敏、王颖撰写论文初稿；孙香娟、张丰华负责构思、设计本研究，监督研究的实施，对文章进行审查，对整个项目负责。
基金资助:
四川省科技厅科研计划项目(2021YJ0153)

Abstract

Abstract:

Background

Functional dyspepsia (FD) is a common clinical disease with numerous guidelines and consensus, but the quality is uneven.

Objective

To explore current status of clinical guidelines and consensus of FD, evaluate and analyze their quality, and provide a reference for future clinical decision-making and guideline revision.

Methods

CNKI, Wanfang Data, VIP, PubMed, Web of Science, Ovid, and Embase were searched from the time of construction to March 30, 2024. Supplemental searches were conducted in databases and publishing platforms, including Guidelines International Network, National Institute for Health and Care Excellence, Scottish Intercollegiate guidelines network, National guideline clearinghouse, Medlive and Chinese Medical Association. The AGREEⅡand RIGHT checklists were used to evaluate the methodological and reporting quality of included studies by well-trained investigators with consistent understanding of the entries independently.

Results

A total of 17 guidelines and consensus were included. The results of AGREEⅡquality evaluation showed that average scores for each of the 6 areas were scope and purpose (71.49±2.38)%, stakeholder involvement (42.48±5.03)%, rigour of development (36.00±5.88)%, clarity of presentation (60.29±5.05)%, applicability (20.47%±2.69%)%, and editorial independence 50.00% (0, 57.29%). 9 literatures were recommended as grade B, 8 literatures as grade C, and no A-rated literature. The results of RIGHT evaluation showed that average reporting rates for each of the seven areas were basic information (70.83±3.03)%, background (68.02±2.98)%, evidence 15.00% (10.00%, 55.00%), recommendation (36.76±3.21)%, review and quality assurance 0 (0, 6.25%), funding and declaration and management of interests (25.37±5.18) %, and other information 16.67% (0, 37.50%).

Conclusion

The overall methodological and reporting quality of clinical guidelines and expert consensus need to be improved, and it is recommended that guidelines should be written in strict accordance with the requirements of AGREE Ⅱand RIGHT checklist.

Key words: Functional dyspepsia, Guideline, Consensus, AGREE Ⅱ, RIGHT, Quality assessment

摘要：

背景

功能性消化不良作为临床常见疾病，其指南及共识众多，但质量参差不齐。

目的

了解功能性消化不良的临床指南与共识的现状，评价和分析其质量，为今后的临床决策和指南的修订及完善提供参考。

方法

检索中国知网、万方数据知识服务平台、维普网、PubMed、Web of Science、Ovid、Embase，同时补充检索国际指南协作网、英国国家卫生与临床优化研究所、苏格兰校际指南网络、美国国立指南库、医脉通、中华医学会等数据库及发布平台；检索时间限定自建库至2024-03-30。由经过培训并对条目理解一致的研究者独立使用AGREE Ⅱ和RIGHT工具对纳入指南进行质量评价。

结果

共纳入指南及共识17篇。AGREE Ⅱ评价结果表明，6个领域的平均得分依次为范围和目的（71.49±2.38）%、参与人员（42.48±5.03）%、严谨性（36.00±5.88）%、清晰性（60.29±5.05）%、应用性（20.47±2.69）%、独立性50.00%（0，57.29%）；9篇推荐等级为B级，8篇推荐等级为C级，无A级文献。RIGHT评价结果显示，7大领域的平均报告率分别为基本信息（70.83±3.03）%、背景（68.02±2.98）%、证据15.00%（10.00%，55.00%）、推荐意见（36.76±3.21）%、评审和质量保证0（0，6.25%）、资助与利益冲突声明和管理（25.37±5.18）%及其他方面16.67%（0，37.50%）。

结论

功能性消化不良的临床实践指南及专家共识方法学及报告质量整体有待提升，建议严格按照AGREE Ⅱ各领域要求及参考RIGHT清单撰写指南。

关键词: 功能性消化不良, 指南, 共识, AGREE Ⅱ, RIGHT, 质量评价

CLC Number:

R 57

TONG Min,WANG Ying,XU Yanshen, et al. Functional Dyspepsia Guideline Quality Assessment: Based on AGREE Ⅱ and RIGHT Tools[J]. Chinese General Practice, 2026, 29(17): 2410-2417. DOI: 10.12114/j.issn.1007-9572.2024.0128.
童敏,王颖,徐衍燊等. 功能性消化不良指南质量评价：基于AGREE Ⅱ和RIGHT工具[J]. 中国全科医学, 2026, 29(17): 2410-2417. DOI: 10.12114/j.issn.1007-9572.2024.0128.

Figures/Tables 10

References 30

[1]	FORD A C, MAHADEVA S, CARBONE M F, et al. Functional dyspepsia[J]. Lancet, 2020, 396(10263): 1689-1702. DOI: 10.1016/S0140-6736(20)30469-4.
[2]	STANGHELLINI V, CHAN F K L, HASLER W L, et al. Gastroduodenal disorders[J]. Gastroenterology, 2016, 150(6): 1380-1392. DOI: 10.1053/j.gastro.2016.02.011.
[3]	FORD A C, MARWAHA A, SOOD R, et al. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis[J]. Gut, 2015, 64(7): 1049-1057. DOI: 10.1136/gutjnl-2014-307843.
[4]	FORD A C, MARWAHA A, LIM A, et al. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2010, 8(10): 830-837, e1-e2. DOI: 10.1016/j.cgh.2010.05.031.
[5]	MAHADEVA S, GOH K L. Epidemiology of functional dyspepsia: a global perspective[J]. World J Gastroenterol, 2006, 12(17): 2661-2666. DOI: 10.3748/wjg.v12.i17.2661.
[6]	BLACK C J, DROSSMAN D A, TALLEY N J, et al. Functional gastrointestinal disorders: advances in understanding and management[J]. Lancet, 2020, 396(10263): 1664-1674. DOI: 10.1016/S0140-6736(20)32115-2.
[7]	Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust[M]. Washington, D.C.: National Academies Press(US), 2011.
[8]	BROUWERS M C, KHO M E, BROWMAN G P, et al. AGREE Ⅱ: advancing guideline development, reporting and evaluation in health care[J]. CMAJ, 2010, 182(18): E839-E842. DOI: 10.1503/cmaj.090449.
[9]	CHEN Y L, YANG K H, MARUŠIC A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement[J]. Ann Intern Med, 2017, 166(2): 128-132. DOI: 10.7326/M16-1565.
[10]	JIANG M, GUAN W J, FANG Z F, et al. A critical review of the quality of cough clinical practice guidelines[J]. Chest, 2016, 150(4): 777-788. DOI: 10.1016/j.chest.2016.04.028.
[11]	中华医学会消化病学分会胃肠功能性疾病协作组, 中华中医药学会脾胃病分会. 西医合理使用中成药治疗功能性消化不良临床指南[J]. 中华消化杂志, 2020, 40(2): 83-86. DOI: 10.3760/cma.j.issn.0254-1432.2020.02.004.
[12]	张声生, 钦丹萍, 周强, 等. 消化系统常见病功能性消化不良中医诊疗指南(基层医生版)[J]. 中华中医药杂志, 2019, 34(8): 3619-3625.
[13]	《中成药治疗优势病种临床应用指南》标准化项目组. 中成药治疗功能性消化不良临床应用指南(2021年)[J]. 中国中西医结合杂志, 2022, 42(1): 5-12.
[14]	BLACK C J, PAINE P A, AGRAWAL A, et al. British Society of Gastroenterology guidelines on the management of functional dyspepsia[J]. Gut, 2022, 71(9): 1697-1723. DOI: 10.1136/gutjnl-2022-327737.
[15]	OH J H, KWON J G, JUNG H K, et al. Clinical practice guidelines for functional dyspepsia in Korea[J]. J Neurogastroenterol Motil, 2020, 26(1): 29-50. DOI: 10.5056/jnm19209.
[16]	MIWA H, NAGAHARA A, ASAKAWA A, et al. Evidence-based clinical practice guidelines for functional dyspepsia 2021[J]. J Gastroenterol, 2022, 57(2): 47-61. DOI: 10.1007/s00535-021-01843-7.
[17]	TALLEY N J, LAM S K, GOH K L, et al. Management guidelines for uninvestigated and functional dyspepsia in the Asia-Pacific region: first Asian Pacific Working Party on Functional Dyspepsia[J]. J Gastroenterol Hepatol, 1998, 13(4): 335-353. DOI: 10.1111/j.1440-1746.1998.tb00644.x.
[18]	中华医学会消化病学分会胃肠动力学组, 中华医学会消化病学分会胃肠功能性疾病协作组. 2022中国功能性消化不良诊治专家共识[J]. 中华消化杂志, 2023, 43(7): 433-446. DOI: 10.3760/cma.j.cn311367-20230206-00048.
[19]	中华中医药学会儿童健康协同创新平台委员会. 儿童功能性消化不良中西医结合诊治专家共识[J]. 中国实用儿科杂志, 2022, 37(1): 7-11. DOI: 10.19538/j.ek2022010602.
[20]	王华宁, 韩壮. 功能性消化不良云南中成药应用专家共识[J]. 中国中医药信息杂志, 2023, 30(1): 1-5. DOI: 10.19879/j.cnki.1005-5304.202208275.
[21]	李军祥, 陈誩, 李岩. 功能性消化不良中西医结合诊疗共识意见(2017年)[J]. 中国中西医结合消化杂志, 2017, 25(12): 889-894.
[22]	张声生, 赵鲁卿. 功能性消化不良中医诊疗专家共识意见(2017)[J]. 中华中医药杂志, 2017, 32(6): 2595-2598.
[23]	郑松柏. 老年人功能性消化不良诊治专家共识[J]. 中华老年病研究电子杂志, 2015, 2(3): 1-7.
[24]	中国中药协会儿童健康与药物研究专业委员会消化学组, 中华医学会儿科学分会消化学组, 中华儿科杂志编辑委员会. 婴幼儿功能性消化不良综合征诊断共识[J]. 中华儿科杂志, 2022, 60(7): 618-620. DOI: 10.3760/cma.j.cn112140-20220129-00097.
[25]	中华医学会儿科学分会消化学组, 中国中药协会儿童健康与药物研究专业委员会消化学组, 中华儿科杂志编辑委员会. 中国儿童功能性消化不良诊断和治疗共识(2022版)[J]. 中华儿科杂志, 2022, 60(8): 751-755. DOI: 10.3760/cma.j.cn112140-20220417-00339.
[26]	MIWA H, GHOSHAL U C, GONLACHANVIT S, et al. Asian consensus report on functional dyspepsia[J]. J Neurogastroenterol Motil, 2012, 18(2): 150-168. DOI: 10.5056/jnm.2012.18.2.150.
[27]	WAUTERS L, DICKMAN R, DRUG V, et al. United European Gastroenterology(UEG)and European Society for Neurogastroenterology and Motility(ESNM)consensus on functional dyspepsia[J]. United European Gastroenterol J, 2021, 9(3): 307-331. DOI: 10.1002/ueg2.12061.
[28]	XIAO Y L, LI Y W, SHU J C, et al. The efficacy of oral Zhizhu Kuanzhong, a traditional Chinese medicine, in patients with postprandial distress syndrome[J]. J Gastroenterol Hepatol, 2019, 34(3): 526-531. DOI: 10.1111/jgh.14467.
[29]	SU Q, CHEN S L, WANG H H, et al. A randomized, double-blind, multicenter, placebo-controlled trial of Qi-Zhi-Wei-Tong Granules on postprandial distress syndrome-predominant functional dyspepsia[J]. Chin Med J, 2018, 131(13): 1549-1556. DOI: 10.4103/0366-6999.235118.
[30]	WEN Y D, LU F, ZHAO Y P, et al. Epigastric pain syndrome: what can traditional Chinese medicine do? A randomized controlled trial of Biling Weitong Granules[J]. World J Gastroenterol, 2020, 26(28): 4170-4181. DOI: 10.3748/wjg.v26.i28.4170.

检索步骤	检索策略
#1	( "Dyspepsia" [Mesh])OR(((((((functional dyspepsia))OR(indigestion))OR(indigestions))OR(dyspepsias))OR(post-prandial distress syndrome))OR(epigastric pain syndrome))
#2	(((((((guidelines)OR(guideline))OR(consensus))OR(CPG))OR(CPGs))OR(recommendation))OR(recommendations))OR(advice)
#3	#1 AND #2

检索步骤	检索策略
#1	( "Dyspepsia" [Mesh])OR(((((((functional dyspepsia))OR(indigestion))OR(indigestions))OR(dyspepsias))OR(post-prandial distress syndrome))OR(epigastric pain syndrome))
#2	(((((((guidelines)OR(guideline))OR(consensus))OR(CPG))OR(CPGs))OR(recommendation))OR(recommendations))OR(advice)
#3	#1 AND #2

指南编号	发表时间（年）	发表机构	基金资助	利益冲突	证据分级	更新	参考文献（条）
指南1^[11]	2020	中华医学会消化病学分会胃肠功能性疾病协作组，中华中医药学会脾胃病分会	未报告	报告	否	否	10
指南2^[12]	2019	中华中医药学会脾胃病分会	报告	未报告	是	否	52
指南3^[13]	2022	《中成药治疗优势病种临床应用指南》标准化项目组	报告	报告	是	否	27
指南4^[14]	2022	British Society of Gastroenterology	报告	报告	是	是	309
指南5^[15]	2020	Korean Society of Neurogastroenterology and Motility（KSNM）	报告	报告	是	是	153
指南6^[16]	2022	Japanese Society of Gastroenterology	报告	报告	是	是	98
指南7^[17]	1998	1st Asian Pacific Working Party	报告	未报告	否	否	123
共识1^[18]	2023	中华医学会消化病学分会胃肠动力学组，中华医学会消化病学分会胃肠功能性疾病协作组	未报告	报告	是	是	143
共识2^[19]	2022	中华中医药学会儿童健康协同创新平台委员会	未报告	未报告	否	否	41
共识3^[20]	2023	云南省中医药学会脾胃病分会，云南女医师协会脾胃肝胆病专业分会，云南省中医医院脾胃病临床医学中心	未报告	未报告	否	否	20
共识4^[21]	2017	中国中西医结合学会消化系统疾病专业委员会	未报告	未报告	否	是	31
共识5^[22]	2017	中华中医药学会脾胃病分会	未报告	未报告	否	否	17
共识6^[23]	2015	中华医学会老年医学分会	未报告	未报告	否	否	57
共识7^[24]	2022	中国中药协会儿童健康与药物研究专业委员会消化学组，中华医学会儿科学分会消化学组，中华儿科杂志编辑委员会	未报告	报告	否	否	13
共识8^[25]	2022	中华医学会儿科学分会消化学组，中国中药协会儿童健康与药物研究专业委员会消化学组，中华儿科杂志编辑委员会	未报告	报告	否	是	32
共识9^[26]	2012	Asian Neurogastroenterology and Motility Association（ANMA）and the Asian Pacific Association of Gastroenterology（APAGE）	报告	报告	是	否	196
共识10^[27]	2021	United European Gastroenterology，European Society for Neurogastroenterology and Motility	报告	报告	是	否	225

指南编号	发表时间（年）	发表机构	基金资助	利益冲突	证据分级	更新	参考文献（条）
指南1^[11]	2020	中华医学会消化病学分会胃肠功能性疾病协作组，中华中医药学会脾胃病分会	未报告	报告	否	否	10
指南2^[12]	2019	中华中医药学会脾胃病分会	报告	未报告	是	否	52
指南3^[13]	2022	《中成药治疗优势病种临床应用指南》标准化项目组	报告	报告	是	否	27
指南4^[14]	2022	British Society of Gastroenterology	报告	报告	是	是	309
指南5^[15]	2020	Korean Society of Neurogastroenterology and Motility（KSNM）	报告	报告	是	是	153
指南6^[16]	2022	Japanese Society of Gastroenterology	报告	报告	是	是	98
指南7^[17]	1998	1st Asian Pacific Working Party	报告	未报告	否	否	123
共识1^[18]	2023	中华医学会消化病学分会胃肠动力学组，中华医学会消化病学分会胃肠功能性疾病协作组	未报告	报告	是	是	143
共识2^[19]	2022	中华中医药学会儿童健康协同创新平台委员会	未报告	未报告	否	否	41
共识3^[20]	2023	云南省中医药学会脾胃病分会，云南女医师协会脾胃肝胆病专业分会，云南省中医医院脾胃病临床医学中心	未报告	未报告	否	否	20
共识4^[21]	2017	中国中西医结合学会消化系统疾病专业委员会	未报告	未报告	否	是	31
共识5^[22]	2017	中华中医药学会脾胃病分会	未报告	未报告	否	否	17
共识6^[23]	2015	中华医学会老年医学分会	未报告	未报告	否	否	57
共识7^[24]	2022	中国中药协会儿童健康与药物研究专业委员会消化学组，中华医学会儿科学分会消化学组，中华儿科杂志编辑委员会	未报告	报告	否	否	13
共识8^[25]	2022	中华医学会儿科学分会消化学组，中国中药协会儿童健康与药物研究专业委员会消化学组，中华儿科杂志编辑委员会	未报告	报告	否	是	32
共识9^[26]	2012	Asian Neurogastroenterology and Motility Association（ANMA）and the Asian Pacific Association of Gastroenterology（APAGE）	报告	报告	是	否	196
共识10^[27]	2021	United European Gastroenterology，European Society for Neurogastroenterology and Motility	报告	报告	是	否	225

评价工具	领域	指南得分报告率[（±s）/M（P₂₅，P₇₅）]	指南1^[11]	指南2^[12]	指南3^[13]	指南4^[14]	指南5^[15]	指南6^[16]	指南7^[17]
AGREE Ⅱ	范围和目的（%）	76.99±3.48	68.06	66.67	88.89	80.56	87.50	77.78	69.44
	参与人员（%）	48.61（45.83，68.06）^a	48.61	68.06	48.61	58.33	81.94	45.83	16.67
	严谨性（%）	50.97±10.46	18.75	27.08	79.17	54.17	88.54	63.02	26.04
	清晰性（%）	70.64±7.80	41.67	48.61	65.28	97.22	91.67	72.22	77.78
	应用性（%）	25.45±3.28	25.00	13.54	27.08	19.79	36.46	36.46	19.79
	独立性（%）	50.00（8.33，93.75）^a	50.00	0	93.75	50.00	100.00	64.58	8.33
	推荐等级（级）		B	C	B	B	B	B	C
RIGHT	基本信息（%）	66.67（66.67，83.33）^a	75.00	66.67	100.00	83.33	66.67	66.67	66.67
	背景（%）	74.56±3.94	68.75	84.38	68.75	62.50	84.38	87.50	65.63
	证据（%）	55.00（15.00，70.00）^a	10.00	15.00	100.00	55.00	70.00	60.00	15.00
	推荐意见（%）	44.90±5.10	39.29	32.14	50.00	64.29	53.57	50.00	25.00
	评审和质量保证（%）	0（0，25.00）^a	0	0	0	25.00	37.50	25.00	0
	资助与利益冲突声明和管理（%）	38.39±7.77	12.50	12.50	50.00	37.50	50.00	68.75	37.50
	其他方面（%）	33.33（8.33，50.00）^a	0	8.33	50.00	41.67	33.33	50.00	33.33

Functional Dyspepsia Guideline Quality Assessment: Based on AGREE Ⅱ and RIGHT Tools

功能性消化不良指南质量评价：基于AGREE Ⅱ和RIGHT工具

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 10

References 30

Related Articles 15

Recommended Articles

Metrics

Comments

评价工具	领域	共识得分报告率[（±s）/M（P₂₅，P₇₅）]	共识1^[18]	共识2^[19]	共识3^[20]	共识4^[21]	共识5^[22]	共识6^[23]	共识7^[24]	共识8^[25]	共识9^[26]	共识10^[27]
AGREE Ⅱ	范围和目的（%）	67.64±2.73	59.72	65.28	62.50	58.33	59.72	72.22	63.89	72.22	81.94	80.56
	参与人员（%）	34.03（18.75，54.17）^a	11.11	19.44	58.33	16.67	20.83	51.39	22.22	45.83	54.17	54.17
	严谨性（%）	25.52±4.89	44.27	8.85	20.83	18.75	16.67	9.38	14.06	27.60	50.52	44.27
	清晰性（%）	53.06±5.88	69.44	48.61	55.56	50.00	48.61	48.61	15.28	47.22	88.89	58.33
	应用性（%）	16.98±3.68	11.46	4.17	8.33	0.00	16.67	15.63	18.75	34.38	30.21	30.21
	独立性（%）	21.88（0，50.00）^a	50.00	0	0	0	0	0	50.00	50.00	100.00	43.75
	推荐等级（级）		B	C	C	C	C	C	C	B	B	B
RIGHT	基本信息（%）	66.67（57.29，83.33）^a	83.33	66.67	54.17	66.67	83.33	66.67	58.33	83.33	50.00	66.67
	背景（%）	63.44±3.73	71.88	71.88	62.50	40.63	50.00	78.13	56.25	62.50	65.63	75.00
	证据（%）	10.00（10.00，43.75）^a	55.00	10.00	10.00	10.00	10.00	10.00	5.00	40.00	35.00	55.00
	推荐意见（%）	31.07±3.20	50.00	21.43	32.14	32.14	32.14	17.86	25.00	21.43	42.86	35.71
	评审和质量保证（%）	0（0，0）^a	12.50	0	0	0	0	0	0	0	0	0
	资助与利益冲突声明和管理（%）	16.25±5.53	12.50	0	6.25	6.25	0	0	25.00	25.00	50.00	37.50
	其他方面（%）	4.17（0，27.08）^a	0	0	8.33	0	0	0	33.33	66.67	25.00	16.67

编号	ICC	95%CI	P值
指南1^[11]	0.958	0.923~0.980	<0.001
指南2^[12]	0.959	0.925~0.981	<0.001
指南3^[13]	0.950	0.908~0.976	<0.001
指南4^[14]	0.973	0.950~0.987	<0.001
指南5^[15]	0.916	0.851~0.959	<0.001
指南6^[16]	0.942	0.894~0.972	<0.001
指南7^[17]	0.942	0.894~0.972	<0.001
共识1^[18]	0.947	0.903~0.974	<0.001
共识2^[19]	0.954	0.916~0.978	<0.001
共识3^[20]	0.935	0.882~0.969	<0.001
共识4^[21]	0.946	0.902~0.974	<0.001
共识5^[22]	0.955	0.918~0.979	<0.001
共识6^[23]	0.976	0.955~0.989	<0.001
共识7^[24]	0.971	0.946~0.986	<0.001
共识8^[25]	0.970	0.945~0.986	<0.001
共识9^[26]	0.964	0.934~0.983	<0.001
共识10^[27]	0.957	0.921~0.979	<0.001

编号	ICC	95%CI	P值
指南1^[11]	0.949	0.901~0.974	<0.001
指南2^[12]	0.889	0.791~0.942	<0.001
指南3^[13]	0.858	0.738~0.926	<0.001
指南4^[14]	0.852	0.726~0.922	<0.001
指南5^[15]	0.881	0.778~0.938	<0.001
指南6^[16]	0.780	0.606~0.882	<0.001
指南7^[17]	0.765	0.582~0.874	<0.001
共识1^[18]	0.768	0.587~0.876	<0.001
共识2^[19]	0.904	0.818~0.950	<0.001
共识3^[20]	0.828	0.685~0.909	<0.001
共识4^[21]	0.801	0.640~0.894	<0.001
共识5^[22]	0.823	0.677~0.906	<0.001
共识6^[23]	0.963	0.928~0.981	<0.001
共识7^[24]	0.851	0.725~0.922	<0.001
共识8^[25]	0.904	0.818~0.950	<0.001
共识9^[26]	0.884	0.783~0.940	<0.001
共识10^[27]	0.843	0.710~0.917	<0.001

辨证分型	推荐汤剂	推荐中成药
脾虚气滞证	六君子汤，香砂六君子汤	胃乃安胶囊，木香顺气丸，六味安消胶囊，枳术宽中胶囊，香砂六君丸，香砂平胃丸，香砂平胃颗粒，香砂枳术丸，香砂养胃片
肝胃不和证	柴胡疏肝散，逍遥散	气滞胃痛颗粒，胃苏颗粒，达立通颗粒，舒肝止痛丸，金佛止痛丸，荜铃胃痛颗粒，元胡止痛片，金胃泰胶囊，猴头健胃灵片，双香顺气胶囊
脾胃湿热证	连朴饮	三九胃泰颗粒，枫蓼肠胃康胶囊，胃肠安丸
脾胃虚寒（弱）证	理中汤，黄芪建中汤，小建中汤	香砂养胃丸，温胃舒胶囊，虚寒胃痛颗粒，理中丸，小建中颗粒，附子理中丸，参苓健脾胃颗粒，桂附理中丸，人参健脾丸
寒热错杂证	半夏泻心汤	温胃舒胶囊，加味左金丸，荆花胃康胶丸

[1]	WANG Yibo, HE Kaiyu, LIANG Guofen, YANG Zhenhua, ZHAO Tingxian, LIAO Biyi, ZHANG La, LIU Shiwei, GONG Xuezhong, LIU Xusheng, GU Yueyu, QIN Xindong, SU Guobin. Diagnosis and Management of Recurrent Urinary Tract Infections in Women: a Comparison and Interpretation Based on Existing Guidelines and Evidence [J]. Chinese General Practice, 2026, 29(17): 2387-2399.
[2]	MENG Zixi, ZHAO Huiduo, LIU Ruidong, WANG Beibei, JIANG Mingqiang, CHENG Xufeng. Guidelines for Diagnosis and Treatment of Acute Mastitis with Integrated Traditional Chinese and Western Medicine [J]. Chinese General Practice, 2026, 29(17): 2273-2281.
[3]	Chinese Nutrition Society Obesity Prevention and Control Branch. Chinese Guidelines for Behavioral and Lifestyle Interventions for Obesity [J]. Chinese General Practice, 2026, 29(16): 2113-2139.
[4]	GUO Jiao, ZHANG Gaojing, LIU Xincan. Quality Evaluation of TCM Clinical Practice Guidelines/Consensus: Based on Two Guideline Evaluation Tools [J]. Chinese General Practice, 2026, 29(15): 2100-2106.
[5]	Nephrology Branch of China Association of Chinese Medicine, Nephrology Committee of Guangdong Provincial Association of Chinese Medicine, SU Peiling, YANG Lihong, BAO Kun. Diagnosis and Treatment Guideline of Integrated Traditional Chinese and Western Medicine for Idiopathic Membranous Nephropathy (2025) [J]. Chinese General Practice, 2026, 29(15): 1953-1970.
[6]	Community Rehabilitation Working Committee of Chinese Rehabilitation Medicine Association. Chinese Expert Consensus on the Management of Home-based Rehabilitation for Cognitive Impairment (2026 Edition) [J]. Chinese General Practice, 2026, 29(14): 1793-1802.
[7]	ZHANG Qiang, ZHAO Wenxia, WANG Ziyi, YAN Le, LIANG Haowei, WANG Jinfan, FANG Jinhua, LU Cuncun. Interpretation of the Reporting Guideline for Systematic Reviews of Outcome Measurement Instruments (PRISMA-COSMIN for OMIs 2024) [J]. Chinese General Practice, 2026, 29(13): 1766-1775.
[8]	SHEN Yong, ZHOU Jingying, WANG Xueping, JIA Meixiang, LIU Jiajia, ZHAN Haojian, WANG Lifang, YAN Hao, PENG Danyuan, YUE Weihua. Construction of Support Services List for Parents of Children with Autism Based on "Timing It Right" Theory [J]. Chinese General Practice, 2026, 29(13): 1688-1698.
[9]	WANG Yeming, ZHOU Qi, LI Jingya, CHEN Siying, WANG Junrui, DUAN Qinlei, CHEN Yaolong, CAO Bin, Respiratory Disease Branch of the Chinese Medical Association, Infectious Diseases Branch of Chinese Medical Association. Chinese Guidelines for the Treatment and Prophylaxis of Influenza in Primary Care (2025 Edition) [J]. Chinese General Practice, 2026, 29(13): 1633-1644.
[10]	YAN Beibei, XU Huaifu. Children's Type 1 Diabetes-specific Self-reported Outcomes Scales: Measurement Properties Evaluation Based on COSMIN Guidelines [J]. Chinese General Practice, 2026, 29(12): 1624-1632.
[11]	WANG Gaoming, WANG Minghang, YANG Jiang, MENG Yuanyuan, ZHAO Di, DONG Xiaosheng. Systematic Evaluation and Reflection on the Quality of Bronchial Asthma Guidelines in China [J]. Chinese General Practice, 2026, 29(10): 1239-1245.
[12]	Chinese Geriatrics Society, National Clinical Research Center for Geriatric Diseases (Xuanwu Hospital). Chinese Expert Consensus on Screening and Comprehensive Assessment of Intrinsic Capacity in Older Adults [J]. Chinese General Practice, 2026, 29(10): 1225-1238.
[13]	China Association of Promoting of Traditional Chinese Medicine, Integrated Medicine Branch of China Medical Association of Minorities, TAO Lili, LIU Yinan, WANG Qiang, LEI Yan. Expert Consensus on the Use of Traditional Chinese Patent Medicines in the Prevention and Treatment of Pan-vascular Diseases and Their Target Organ Damage [J]. Chinese General Practice, 2026, 29(09): 1089-1108.
[14]	Expert Panel of the Consensus on Artificial Intelligence Empowering Healthcare Services. Artificial Intelligence Empowering Healthcare Services: Expert Consensus from the Mangrove Health Conference in 2025 [J]. Chinese General Practice, 2026, 29(07): 817-822.
[15]	CHEN Chuping, LIU Lidi, YANG Ziyu, ZHANG Peng, ZHANG Rui, YUAN Bo, SHEN Can, YANG Rong, LI Dongze, LIAO Xiaoyang, LEI Yi. Implications for the Management of Chronic Obstructive Pulmonary Disease Patients Based on the Italian Consensus in 2024: Triple Inhalation Therapy in Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2026, 29(06): 688-692.